홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
Recent advances in phosphatases as new biomarker in personalized medicine | Synapse
March 3, 2026
Recent advances in phosphatases as new biomarker in personalized medicine
SG
Shreya Y. Garge
GG
Gayatri Gaikwad
VS
Vasanti Suvarna
Key Points
Phosphatases serve as crucial biomarkers, influencing treatment decisions in personalized medicine.
Recent findings highlight their role in various molecular pathways, impacting patient outcomes significantly.
Observational analysis focuses on the connection between phosphatases and treatment efficacy across diverse patient populations.
These insights support the potential of phosphatases in guiding personalized therapies, though further validation is necessary.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Garge et al. (Thu,) studied this question.
synapsesocial.com/papers/69a766f9badf0bb9e87df28a
https://doi.org/https://doi.org/10.1016/j.cca.2026.120880